Raffles Medical Group Ltd BSL
SGX · Singapore · Health Services
SGD 0.8200-0.01 (-1.20%)
Market closed· · SGD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · SGD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced today that it has signed a supply agreement with Raffles Medical for its neurodegenerative brain imaging analysis software, Neurophet AQUA.
Potential Raffles Medical Group Ltd ( SGX:BSL ) shareholders may wish to note that the Executive Chairman & CEO, Choon...
Raffles Medical Group Ltd ( SGX:BSL ) stock is about to trade ex-dividend in four days. Typically, the ex-dividend date...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.